CHRISTY VATH: Open Payments
NPI 1427044510 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,283 in 181 payments from 21 companies in 2025. Trend: 2023 $16,464 · 2024 $5,975 · 2025 $20,283
Consulting: $9,970Food & beverage: $4,535Speaker / faculty: $2,925Travel & lodging: $2,797Education: $55
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 40 | $13,373 |
| Janssen Biotech, Inc. | 24 | $2,446 |
| AstraZeneca Pharmaceuticals LP | 15 | $2,050 |
| ABBVIE INC. | 30 | $864 |
| Novartis Pharmaceuticals Corporation | 20 | $379 |
| Amgen Inc. | 15 | $328 |
| Lilly USA, LLC | 6 | $151 |
| Genentech USA, Inc. | 8 | $135 |
| Alexion Pharmaceuticals, Inc. | 4 | $93 |
| PFIZER INC. | 3 | $75 |
Products named: Bimzelx, TREMFYA, RINVOQ, SAPHNELO, COSENTYX, SKYRIZI, TALTZ, EVENITY.
Industry payments across WA — which companies pay providers there.
